NCT05631093 · Interventional trial
A Switch to Doravirine/Islatravir (DOR/ISL) in Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Who Are Virologically Suppressed on Antiretroviral Therapy (ART) (MK-8591A-051)
Overall registry status Active not recruiting
Phase 3
Conditions HIV-1 Infection
Delaware Valley sites
- Penn Medicine: University of Pennsylvania Health System-Perelman Center for Advanced Medicine ( Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory